Bristol Myers BMY announced that the European Commission (EC) has approved the blockbuster immuno-oncology drug Opdivo ...

The panelist discusses how for patients initially eligible for embolization, systemic therapy may be combined with ...

Liver cancer in the Philippines holds a staggering mortality rate of 11.6 out of 100,000 individuals, compared to the global death rate of 7.8/100,000. This reflects the significant impact of liver ...

Hepatocellular carcinoma is a leading cause of cancer-related death globally. The treatment of hepatocellular carcinoma is complex, with diverse therapeutic approaches and their combinations available ...

Department of Gastroenterology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan Department of Clinical and Molecular Genetics, Hiroshima University, ...

This is encouraging as AFP is a liver cancer biomarker where high AFP ... About primary liver cancer Primary liver cancer is the third leading cause of cancer-related deaths worldwide. Hepatocellular ...

Hepatocellular carcinoma (HCC), the most common type of liver tumor, is a leading cause of cancer-related deaths, and the incidence of liver cancer is still increasing worldwide. Curative hepatectomy ...

1Division of Life Sciences and Medicine, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Key Laboratory of Immune Response and Immunotherapy, School of Basic Medical Sciences, ...

1Division of Hematology/Oncology, University of California, San Francisco, San Francisco, California. 2Quantitative Biosciences Institute, University of California ...

This significant progress further solidifies Lion TCR's leading position in the mRNA-based TCR-T field and brings new hope to patients with hepatocellular carcinoma (HCC). Hepatitis B and liver ...

0 = No cancer-related symptoms. Normal lifestyle. 1 = Minor symptoms related to cancer. Capable of nonstrenuous activity. Fully ambulatory. 2 = Ambulatory and capable of all self-care but unable ...